• In early June 2026, Uber Technologies, Inc. announced a partnership with WeRide and AVOMO to launch Spain’s first commercial Robotaxi pilot in Madrid, while WeRide also secured Slovak government backing to deploy its full Level 4 autonomous portfolio across smart mobility, public transport, logistics, and sanitation starting with tests in Bratislava.
• Together, these moves show WeRide using an asset-light, partner-led model to enter Europe with both commercial robotaxi pilots and multi-use government-supported deployments, potentially broadening its geographic and product footprint.
• We’ll now explore how WeRide’s Uber-backed Madrid robotaxi pilot could reshape its investment narrative around scaling autonomous mobility in new markets.

AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

WeRide Investment Narrative Recap

To own WeRide, you need to believe that its asset light, partner led robotaxi and L4 portfolio can eventually scale into sustainable, higher margin service revenue despite today’s losses and dilution. The Uber and AVOMO backed Madrid pilot and Slovakia rollout touch the core near term catalyst of winning new cities while also highlighting the biggest risk: heavy R&D and expansion spend without clear evidence yet that utilization and revenue can catch up fast enough to narrow losses.

Among recent announcements, the February 2026 plan to deploy at least 1,200 robotaxis across Abu Dhabi, Dubai and Riyadh by 2027 looks most connected to the Madrid and Slovakia news. Both the Middle East expansion and the new European moves lean on Uber integration, local fleet partners and city level permits, reinforcing the same catalyst around scaling utilization in high fare, driver constrained markets while also testing how far WeRide’s partnership model can stretch before costs and execution risk bite.

Yet while the story sounds promising, investors should also be aware that WeRide’s heavy ongoing R&D spend and rising net losses could...

WeRide's narrative projects CN¥6.7 billion revenue and CN¥358.0 million earnings by 2029. This requires 136.1% yearly revenue growth and about a CN¥2.1 billion earnings increase from CN¥-1.7 billion today.

Uncover how WeRide's forecasts yield a $15.22 fair value, a 142% upside to its current price.

Exploring Other Perspectives

Before this Madrid news, the most optimistic analysts were already assuming revenue could grow about 150% a year to roughly CN¥8,000,000,000 by 2028, which is far more upbeat than the baseline view that focuses on regulatory and utilization risks rather than such rapid scaling, so it is worth asking how the Uber backed European entry might shift those expectations and what that could mean if the dependence on a few large partners starts to look more like a vulnerability than a strength.

Explore 10 other fair value estimates on WeRide - why the stock might be a potential multi-bagger!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your WeRide research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free WeRide research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate WeRide's overall financial health at a glance.

Searching For A Fresh Perspective?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• We've uncovered the 8 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Find 46 companies with promising cash flow potential yet trading below their fair value.
• Explore 29 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.